Multiple mechanisms of lung surfactant inhibition

Pediatric Research

Volumn 46, Issue 1, 1999, Pages 85-93

  Holm, Bruce A ^a,b   Wang, Zhengdong ^c   Notter, Robert H ^c,d,e,f  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e University of Rochester   (United States)

^f UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LUNG SURFACTANT EXTRACT; LYSOPHOSPHATIDYLCHOLINE;

ADSORPTION; ARTICLE; COMPRESSION; PRIORITY JOURNAL; SURFACE PROPERTY; SURFACE TENSION;

EID: 0032977701     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199907000-00015     Document Type: Article

References (52)

1. Ashbaugh D, Bigelow D, Petty T, Levine B 1967 Acute respiratory distress in adults. Lancet 2:319-323
2. Petty TL, Ashbaugh DG 1971 The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management. Chest 60:233-239
3. Lewis JF, Jobe AH 1993 Surfactant and ARDS. Am Rev Respir Dis 147:218-233
4. Seeger W, Gunther A, Walmrath HD, Grimminger F, Lasch HG 1993 Alveolar surfactant and adult respiratory distress syndrome: pathogenic role and therapeutic prospects. Clin Invest 71:177-190
5. Bernard GR, Artigas A, Brigham K, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, and the Consensus Committee 1994 The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824
6. Koleff MH, Schuster DP 1995 The acute respiratory distress syndrome. N Engl J Med 332:27-37
7. Krafft P, Fridrich P, Pernerstorfer T, Fitzgerald RD, Koc D, Schneider B, Hammerle AF, Steltzer H 1996 The acute respiratory distress syndrome; definitions, severity and clinical outcome: an analysis of 101 clinical investigations. Intensive Care Med 22:519-529
8. Notter RH, Wang Z 1997 Pulmonary surfactant: physical chemistry, physiology, and replacement. Rev Chem Eng 13:1-118
9. Holm BA, Notter RH, Finkelstein JN 1985 Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38:287-298
10. Seeger W, Stöhr G, Wolf HRD, Neuhof H 1985 Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58:326-338
11. Holm BA, Notter RH 1987 Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63:1434-1442
12. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G 1987 Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62:429-437
13. Holm BA, Enhorning G, Notter RH 1988 A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49:49-55
14. Keough KMW, Parsons CS, Tweeddale MG 1989 Interactions between plasma proteins and pulmonary surfactant: pulsating bubble studies. Can J Physiol Pharmacol 67:663-668
15. Cockshutt AM, Weitz J, Possmayer F 1990 Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424-8429
16. Venkitaraman AR, Hall SB, Whitsett JA, Notter RH 1990 Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein admixtures by surfactant protein A. Chem Phys Lipids 56:185-194
17. Venkitaraman AR, Baatz JE, Whitsett JA, Hall SB, Notter RH 1991 Biophysical inhibition of synthetic phospholipid-surfactant protein admixtures by plasma proteins. Chem Phys Lipids 57:49-57
18. Hall SB, Lu RZ, Venkitaraman AR, Hyde RW, Notter RH 1992 Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics. J Appl Physiol 72:1708-1716
19. Seeger W, Grube C, Gunther A, Schmidt R 1993 Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6:971-977
20. Holm BA, Notter RH, Siegle J, Matalon S 1985 Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 59:1402-1409
21. Berry D, Ikegami M, Jobe A 1986 Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 61:1741-1748
22. Liau DF, Barrett CR, Bell ALL, Ryan SF 1987 Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog. Am Rev Respir Dis 136:395-401
23. Hall SB, Notter RH, Smith RJ, Hyde RW 1990 Altered function of pulmonary surfactant in fatty acid lung injury. J Appl Physiol 69:1143-1149
24. Lewis J, Ikegami M, Jobe A 1990 Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 69:2303-2310
25. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L 1982 Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70:673-683
26. Seeger W, Pison U, Buchhorn R, Obestacke U, Joka T 1990 Surfactant abnormalities and adult respiratory failure. Lung (suppl):891-902
27. Gregory T, Longmore W, Moxley M, Whitsett J, Reed C, Fowler A, Hudson L, Maunder R, Crim C, Hyers T 1991 Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 65:1976-1981
28. Holm BA, Keicher L, Liu M, Sokolowski J, Enhorning G 1991 Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 71:1-5
29. Enhorning G, Shumel B, Keicher L, Sokolowski J, Holm BA 1992 Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble. J Appl Physiol 73:941-945
30. Notter RH, Finkelstein J, Taubold R 1983 Comparative adsorption of natural lung surfactant, extracted phospholipids, and artificial phospholipid mixtures to the air-water interface. Chem Phys Lipids 33:67-80
31. Notter RH, Penney DP, Finkelstein JN, Shapiro DL 1986 Adsorption of natural LS and phospholipid extracts related to tubular myelin formation. Pediatr Res 20:97-101
32. Bligh E, Dyer W 1959 A rapid method of total lipid extraction and purification. Can J Biochem 37:911-917
33. Ames BN 1966 Assay of inorganic phosphate, total phosphate and phosphatases. Meth Enzymol 8:115-118
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
35. Touchstone JC, Chen JC, Beaver KM 1980 Improved separation of phospholipids in thin layer chromatography. Lipids 15:61-62
36. Hall SB, Wang Z, and Notter RH 1994 Separation of the hydrophobic components of calf lung surfactant. J Lipid Res 35:1386-1394
37. Enhorning G. 1977 Pulsating bubble technique for evaluation of pulmonary surfactant. J Appl Physiol 43:198-203
38. Hall SB, Bermel MS, Ko YT, Palmer HJ, Enhorning G, Notter RH 1993 Approximations in the measurement of surface tension on the oscillating bubble surfactometer. J Appl Physiol 75:467-478
39. Tabak SA, Notter RH 1977 A modified technique for dynamic surface pressure and relaxation measurements at the air-water interface. Rev Sci Instrum 48:1196-1201
40. Stafford RE, Fanni T, Dennis EA 1989 Interfacial properties and critical micelle concentrations of lysophospholipids. Biochemistry 28:5113-5120
41. Tabak SA, Notter RH 1977 Effects of plasma proteins on the dynamic π-A characteristics of films of saturated phospholipids. J Colloid Interface Sci 59:293-300
42. Hall SB, Hyde RW, Notter RH 1994 Changes in subphase aggregates in rabbits injured by free fatty acid. Am J Respir Crit Care Med 149:1099-1106
43. Holm BA, Venkitaraman AR, Enhorning G, Notter RH 1990 Biophysical inhibition of synthetic lung surfactants. Chem Phys Lipids 52:243-250
44. Amirkhanian JD, Taeusch HW 1993 Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. Biochim Biophys Acta 1165:321-326
45. Helenius A, Simon K 1975 Solubilization of membranes by detergents. Biochim Biophys Acta 415:27-79
46. Weltzien HU 1979 Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta 559:259-287
47. Malik AB 1983 Pulmonary edema after pancreatitis: role of humoral factors. Circ Shock 10:71-80
48. 2 in the pathobiology of disease. Lab Invest 55:391-404
49. 2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative shock. J Lab Clin Med 104:837-881
50. Offenstadt G, Pinta P, Masliah J, Alcindor LG, Hericord P, Amstutz P 1981 Phospholipase and phospholipasic activities in bronchoalveolar lavage fluid in severe acute pulmonary diseases with or without ARDS. Intensive Care Med 7:285-291
51. Von Wichert P, Temmesfeld M, Meyer W 1981 Influence of septic shock upon phosphatidylcholine remodeling mechanisms in rat lung. Biochim Biophys Acta 664:487-492
52. Wang Z, Notter RH 1998 Additivity of protein and non-protein inhibitors of lung surfactant. Am J Respir Crit Care Med 158:28-35